文献速递临床试验与 GCP流行病学与生物统计

重度精神疾病戒烟干预机会:TIMER随机对照试验方案

Smoking cessation opportunities in severe mental illness (tobacco intensive motivational and estimate risk - TIMER-): study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2019-01-14

针对精神分裂症或双相障碍的吸烟者,设计多中心随机12个月随访试验,最少纳入204名40岁及以上吸烟者。干预组依据 spirometry 评估的肺龄和COPD风险给予强化动机信息并辅以3个月个体化短信,主要结局为随访末经 cooximetry 确认的戒烟。

要点

  • 重度精神疾病患者过早死亡风险升高,吸烟是可预防的关键因素。
  • 干预基于肺龄和肺部损伤风险个体化动机信息,并辅以3个月短信强化。
  • 戒烟结局用 cooximetry 确认,COPD诊断与分期由呼吸科医生验证。

核心结论

  • 在社区照护背景下,筛查和早期发现肺损伤结合移动技术提供预防信息,可能为重度精神疾病患者提供更好的戒烟机会。

研究设计与样本

  • 随机、12个月随访、多中心研究,最少纳入204名40岁及以上吸烟者,均诊断为精神分裂症或双相障碍。

主要发现

  • 该文为试验方案,未报告干预效果或组间比较结果。

关键数值与推荐

  • COPD通过 spirometry 评估,诊断由呼吸科医生验证,并估算肺龄。
  • 干预组基于肺龄值接受预防动机信息,并接受3个月个体化短信强化。
  • 随访末戒烟通过 cooximetry 确认,并评估COPD诊断和疾病分期严重程度。

临床怎么用

  • 对精神分裂症或双相障碍的40岁及以上吸烟者,可考虑筛查肺损伤并用肺龄信息进行戒烟动机干预。

局限性

  • 本文为研究方案,尚缺乏干预效果数据;试验状态为招募中。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is an increased risk of premature death in people with severe mental illness (SMI). Respiratory disorders and cardiovascular disease are leading causes of increased mortality rates in these patients, and tobacco consumption remains the most preventable risk factor involved. Developing new tools to motivate patients towards cessation of smoking is a high priority. Information on the motivational value of giving the lung age and prevention opportunities is unknown in this high-risk population. METHODS/DESIGN: This article describes in detail a protocol developed to evaluate an intensive motivational tool, based on the individual risks of pulmonary damage and prevention opportunities. It is designed as a randomized, 12-month, follow-up, multicenter study. A minimum of 204 smokers will be included, aged 40 years and older, all of whom are patients diagnosed with either schizophrenia or bipolar disorder (BD). Chronic obstructive pulmonary disease (COPD) will be evaluated using spirometry, and the diagnosis will then be validated by a pneumologist and the lung age estimated. Based on this value, a motivational message about prevention will be issued for the intervention group, which will be reinforced by individualized text messages over a period of 3 months. The efficacy of the method and the pulmonary damage variables will be evaluated: smoking cessation at the end of follow-up will be confirmed by cooximetry, and the COPD diagnosis and the severity of the staging for disease will be assessed. DISCUSSION: In the context of community care, screening and early detection of lung damage could potentially be used, together with mobile technology, in order to produce a prevention message, which may provide patients with SMI with a better chance of quitting smoking. TRIAL REGISTRATION: ClinicalTrials.gov, ID: NCT03583203 . Registered on 11 July 2018. Trial status: recruitment.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Jaén-Moreno MJ, Feu N, Redondo-Écija J, et al. Smoking cessation opportunities in severe mental illness (tobacco intensive motivational and estimate risk - TIMER-): study protocol for a randomized controlled trial. Trials. 2019. PMID: 30642365. doi:10.1186/s13063-018-3139-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。